Uninterrupted non–vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation-Reference-Cited by-同舟云学术

Uninterrupted non–vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation

Published:2019-04 Issue:4 Volume:82 Page:256-259
ISSN:1726-4901
Container-title:Journal of the Chinese Medical Association
language:en
Short-container-title:

Author:

Tsai Chuan-Tsai,Liao Jo-Nan,Chao Tze-Fan,Lin Yenn-Jiang,Chang Shih-Lin,Lo Li-Wei,Hu Yu-Feng,Chung Fa-Po,Tuan Ta-Chuan,Chen Shih-Ann

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference19 articles.

1. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.;Douketis;Chest,2012

2. Pacemaker or defibrillator surgery without interruption of anticoagulation.;Birnie;N Engl J Med,2013

3. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.;Heidbuchel;Europace,2015

4. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.;Kirchhof;Eur Heart J,2016

5. Lead perforation: incidence in registries.;Carlson;Pacing Clin Electrophysiol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs;International Journal of Environmental Research and Public Health;2022-09-21

2. Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper;Thrombosis and Haemostasis;2022-07-06

3. Pocket hematoma after pacemaker or defibrillator surgery: Direct oral anticoagulants versus vitamin K antagonists;IJC Heart & Vasculature;2022-04

4. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society;EP Europace;2022-03-22

5. Cardiac Tamponade Caused by Atrial Lead Perforation or by Spontaneous Hemopericardium in an Edoxaban User;INT J GERONTOL;2022